Cyber & AI: GSK, Responsible use of AI in pharma

Since 2011, EOS has engaged with GSK on several issues, recently focusing on responsible AI in pharma. In November 2023, EOS encouraged GSK to publicly outline how it ensures ethical AI use. Following EOS’s feedback on board oversight and reporting practices, GSK published its Responsible Use of AI Policy in March 2024, clearly demonstrating its commitment to ethical standards. EOS considers this engagement objective complete and will continue to monitor implementation.

At time of publishing, May 2025, RBC Asset Management is one of our partners on our Global Sustainable Equity portfolio